ELI LILLY & Co
Close on Nov 2, 2026Market cap $1.33TP/E 45.8Yield 0.44%
Eli Lilly U.S. GTN rebate, discount & return liability rollforward by Year
U.S. GTN rebate, discount & return liability rollforward — Ending balance ($M) ($M)
Eli Lilly U.S. GTN rebate, discount & return liability rollforward: $15,148M in FY2025, up 46.9% from a year earlier. That is the highest of the 10 years on record here.
Where the FY2025 figure comes from
“|| Sales rebate, discount, and return liabilities, end of year | $ | 15,148 | $ | 10,313 (1)Adjustments of the estimates for these rebates, discounts, and returns to actual results were less than 2 percent of consolidated revenue for each of the years presented.”
Source: Form 10-K FY2025 (filed 2026-02-12) ↗
Reported in Form 10-K Item 7 Gross-to-Net (GTN) Rollforward Table (FY2016 → FY2025).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | U.S. GTN rebate, discount & return liability rollforward — Ending balance ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 15,148 | +46.9% | Form 10-K FY2025 (filed 2026-02-12) ↗ |
| FY2024 | Dec 31, 2024 | 10,313 | -3.3% | Form 10-K FY2024 (filed 2025-02-19) ↗ |
| FY2023 | Dec 31, 2023 | 10,668 | +29.9% | Form 10-K FY2023 (filed 2024-02-21) ↗ |
| FY2022 | Dec 31, 2022 | 8,214 | +33.3% | Form 10-K FY2022 (filed 2023-02-22) ↗ |
| FY2021 | Dec 31, 2021 | 6,162 | +14.1% | Form 10-K FY2021 (filed 2022-02-23) ↗ |
| FY2020 | Dec 31, 2020 | 5,400 | +16.5% | Form 10-K FY2020 (filed 2021-02-17) ↗ |
| FY2019 | Dec 31, 2019 | 4,636 | -0.9% | Form 10-K FY2019 (filed 2020-02-19) ↗ |
| FY2018 | Dec 31, 2018 | 4,678 | +12.1% | Form 10-K FY2018 (filed 2019-02-19) ↗ |
| FY2017 | Dec 31, 2017 | 4,172 | +15.8% | Form 10-K FY2017 (filed 2018-02-20) ↗ |
| FY2016 | Dec 31, 2016 | 3,602 | – | Form 10-K FY2017 (filed 2018-02-20) ↗ |
Breakdown
What makes up U.S. GTN rebate, discount & return liability rollforward
Cite this data
StockData. (2026). Eli Lilly U.S. GTN rebate, discount & return liability rollforward ($M), annual FY2016–FY2025 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/gtn-us-end
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.